# Immunology Sector Canonical URL: https://biopharmsignal.com/sector/immunology Immunology includes companies working on autoimmune disease, inflammation, allergy, and immune-modulating therapies. This sector page brings together names focused on controlling overactive immune pathways or restoring immune balance across chronic inflammatory disorders. Companies currently grouped under Immunology: 95 ## Recent Sector News - 2026-07-27 20:01 EST — KYMR — [Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer](https://biopharmsignal.com/news/KYMR/kymera-therapeutics-appoints-terence-rooney-md-as-chief-medical-officer-93d7b265) — Source: Kymera - 2026-07-27 05:00 EST — ARGX — [argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline](https://biopharmsignal.com/news/ARGX/argenx-to-acquire-forte-biosciences-inc-adding-first-in-class-anti-cd122-antibod-fae8b638) — Source: Argenx - 2026-07-23 20:05 EST — IMVT — [Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026](https://biopharmsignal.com/news/IMVT/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026--73653d45) — Source: Immunovant - 2026-07-23 05:00 EST — ARGX — [argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update](https://biopharmsignal.com/news/ARGX/argenx-reports-half-year-2026-financial-results-and-provides-second-quarter-busi-a7cfe76d) — Source: Argenx - 2026-07-22 11:00 EST — AVTX — [Avalo Therapeutics to Participate in the BTIG Biotechnology Conference](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-to-participate-in-the-btig-biotechnology-conference-399b4284) — Source: Avalo Therapeutics - 2026-07-21 10:45 EST — BNTX — [BioNTech veröffentlicht am 4. August 2026 Ergebnisse für das zweite Quartal 2026 und informiert über operativen Fortschritt](https://biopharmsignal.com/news/BNTX/biontech-ver-ffentlicht-am-4-august-2026-ergebnisse-f-r-das-zweite-quartal-2026--87f9447b) — Source: BioNTech - 2026-07-21 10:45 EST — BNTX — [BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026](https://biopharmsignal.com/news/BNTX/biontech-to-report-second-quarter-2026-financial-results-and-corporate-update-on-aeeb45ba) — Source: BioNTech - 2026-07-20 10:59 EST — BMY — [Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA](https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-build-the-most-powerful-ai-factory-in-life-sciences-with-eb3e7bda) — Source: BMYBristol-Myers Squibb Company - 2026-07-16 05:00 EST — ARGX — [argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026](https://biopharmsignal.com/news/ARGX/argenx-to-report-half-year-2026-financial-results-and-second-quarter-business-up-391e9c59) — Source: Argenx - 2026-07-13 10:59 EST — BMY — [U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma](https://biopharmsignal.com/news/BMY/u-s-food-and-drug-administration-accepts-bristol-myers-squibb-s-new-drug-applica-b21b9788) — Source: BMYBristol-Myers Squibb Company - 2026-07-08 11:30 EST — CMMB — [Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis](https://biopharmsignal.com/news/CMMB/chemomab-therapeutics-and-precision-medicine-pioneer-scipher-medicine-announce-m-14c02ebe) — Source: Chemomab Therapeutics - 2026-07-07 12:00 EST — SABS — [Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes](https://biopharmsignal.com/news/SABS/breakthrough-t1d-awards-grant-to-support-prise-hatg-study-of-sab-142-in-stage-3--2892a9e2) — Source: SAB Biotherapeutics - 2026-07-07 11:00 EST — KYMR — [Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader](https://biopharmsignal.com/news/KYMR/kymera-therapeutics-appoints-elizabeth-laws-ph-d-as-senior-vice-president-global-f322a3cc) — Source: Kymera - 2026-07-07 11:00 EST — AVTX — [Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-to-participate-in-the-leerink-partners-therapeutics-forum-ef62dbcf) — Source: Avalo Therapeutics - 2026-06-29 11:30 EST — ZURA — [Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program](https://biopharmsignal.com/news/ZURA/zura-bio-exceeds-enrollment-target-in-both-hidradenitis-suppurativa-hs-systemic--cfd7a19d) — Source: Zura Bio - 2026-06-26 11:00 EST — AVTX — [Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-to-join-the-russell-2000-and-russell-3000-indexes-3ee6d18b) — Source: Avalo Therapeutics - 2026-06-25 11:00 EST — KYMR — [Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026](https://biopharmsignal.com/news/KYMR/kymera-therapeutics-completes-enrollment-in-the-phase-2b-broaden2-trial-of-kt-62-eddcfec5) — Source: Kymera - 2026-06-24 20:01 EST — KYMR — [Kymera Therapeutics Appoints Felix J. Baker, Ph.D., as Chairman of the Board of Directors](https://biopharmsignal.com/news/KYMR/kymera-therapeutics-appoints-felix-j-baker-ph-d-as-chairman-of-the-board-of-dire-f3d892d4) — Source: Kymera - 2026-06-23 11:00 EST — AVTX — [Avalo Therapeutics Appoints Ron Philip to Board of Directors](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-appoints-ron-philip-to-board-of-directors-7373732c) — Source: Avalo Therapeutics - 2026-06-23 05:00 EST — ARGX — [argenx to Host Autoimmune Myositis R&D Webinar](https://biopharmsignal.com/news/ARGX/argenx-to-host-autoimmune-myositis-r-d-webinar-30608012) — Source: Argenx ## Companies - [ABBV](https://biopharmsignal.com/company/ABBV) — AbbVie Inc - [SLRN](https://biopharmsignal.com/company/SLRN) — ACELYRIN, INC. - [ACHL](https://biopharmsignal.com/company/ACHL) — Achilles Therapeutics - [ACRS](https://biopharmsignal.com/company/ACRS) — Aclaris Therapeutics - [ALDX](https://biopharmsignal.com/company/ALDX) — Aldeyra Therapeutics, Inc. - [ALEC](https://biopharmsignal.com/company/ALEC) — Alector - [ALLK](https://biopharmsignal.com/company/ALLK) — Allakos - [ALPN](https://biopharmsignal.com/company/ALPN) — Alpine Immune Sciences - [ANAB](https://biopharmsignal.com/company/ANAB) — AnaptysBio, Inc. - [APLS](https://biopharmsignal.com/company/APLS) — Apellis Pharmaceuticals - [APGE](https://biopharmsignal.com/company/APGE) — Apogee Therapeutics - [ARGX](https://biopharmsignal.com/company/ARGX) — Argenx - [ARGS](https://biopharmsignal.com/company/ARGS) — Argos - [ASLN](https://biopharmsignal.com/company/ASLN) — ASLAN Pharmaceuticals - [ATRA](https://biopharmsignal.com/company/ATRA) — Atara Biotherapeutics, Inc. - [ATYR](https://biopharmsignal.com/company/ATYR) — aTyr Pharma - [AUPH](https://biopharmsignal.com/company/AUPH) — Aurinia Pharmaceuticals Inc - [AVTX](https://biopharmsignal.com/company/AVTX) — Avalo Therapeutics - [BHVN](https://biopharmsignal.com/company/BHVN) — Biohaven - [BNTX](https://biopharmsignal.com/company/BNTX) — BioNTech - [BMY](https://biopharmsignal.com/company/BMY) — BMYBristol-Myers Squibb Company - [CABA](https://biopharmsignal.com/company/CABA) — Cabaletta Bio - [CALC](https://biopharmsignal.com/company/CALC) — CalciMedica - [CRDL](https://biopharmsignal.com/company/CRDL) — Cardiol Therapeutics Inc - [RNAC](https://biopharmsignal.com/company/RNAC) — Cartesian Therapeutics - [CLDX](https://biopharmsignal.com/company/CLDX) — Celldex Therapeutics - [CMMB](https://biopharmsignal.com/company/CMMB) — Chemomab Therapeutics - [CNTB](https://biopharmsignal.com/company/CNTB) — Connect Biopharma Holdings Limited - [CUE](https://biopharmsignal.com/company/CUE) — Cue Biopharma Inc - [ELDN](https://biopharmsignal.com/company/ELDN) — Eledon Pharmaceuticals, Inc. - [LLY](https://biopharmsignal.com/company/LLY) — Eli Lilly - [ENTA](https://biopharmsignal.com/company/ENTA) — Enanta Pharmaceuticals - [EQ](https://biopharmsignal.com/company/EQ) — Equillium, Inc. - [EVAX](https://biopharmsignal.com/company/EVAX) — Evaxion Biotech - [XGN](https://biopharmsignal.com/company/XGN) — Exagen - [FWBI](https://biopharmsignal.com/company/FWBI) — First Wave BioPharma - [FBRX](https://biopharmsignal.com/company/FBRX) — Forte Biosciences - [FRTX](https://biopharmsignal.com/company/FRTX) — Fresh Tracks Therapeutics - [GLPG](https://biopharmsignal.com/company/GLPG) — Galapagos NV - [GOSS](https://biopharmsignal.com/company/GOSS) — Gossamer Bio - [GRI](https://biopharmsignal.com/company/GRI) — GRI Bio - [GYRE](https://biopharmsignal.com/company/GYRE) — Gyre Therapeutics - [HCWB](https://biopharmsignal.com/company/HCWB) — HCW Biologics - [HCM](https://biopharmsignal.com/company/HCM) — HUTCHMED - [IMAB](https://biopharmsignal.com/company/IMAB) — I-MABDR - [IDRA](https://biopharmsignal.com/company/IDRA) — Idera - [IMUX](https://biopharmsignal.com/company/IMUX) — Immunic - [IMVT](https://biopharmsignal.com/company/IMVT) — Immunovant - [IMMP](https://biopharmsignal.com/company/IMMP) — Immutep Limited - [INCY](https://biopharmsignal.com/company/INCY) — Incyte - [IFRX](https://biopharmsignal.com/company/IFRX) — Inflarx NV - [INMB](https://biopharmsignal.com/company/INMB) — INmune Bio - [KZR](https://biopharmsignal.com/company/KZR) — Kezar Life Sciences - [KA](https://biopharmsignal.com/company/KA) — Kineta - [KNSA](https://biopharmsignal.com/company/KNSA) — Kiniksa - [KYMR](https://biopharmsignal.com/company/KYMR) — Kymera - [KYTX](https://biopharmsignal.com/company/KYTX) — Kyverna Therapeutics - [LABP](https://biopharmsignal.com/company/LABP) — Landos Biopharma - [MREO](https://biopharmsignal.com/company/MREO) — Mereo BioPharma - [MACK](https://biopharmsignal.com/company/MACK) — Merrimack - [MRUS](https://biopharmsignal.com/company/MRUS) — Merus - [MRNA](https://biopharmsignal.com/company/MRNA) — Moderna, Inc. - [MLTX](https://biopharmsignal.com/company/MLTX) — MoonLake Immunotherapeutics - [MOR](https://biopharmsignal.com/company/MOR) — MorphoSys - [MYMD](https://biopharmsignal.com/company/MYMD) — MyMD Pharmaceuticals - [NKTR](https://biopharmsignal.com/company/NKTR) — Nektar Therapeutics - [NVS](https://biopharmsignal.com/company/NVS) — Novartis AG - [NRIX](https://biopharmsignal.com/company/NRIX) — Nurix Therapeutics - [OCEA](https://biopharmsignal.com/company/OCEA) — Ocean Biomedical - [OMER](https://biopharmsignal.com/company/OMER) — Omeros - [PIRS](https://biopharmsignal.com/company/PIRS) — Pieris - [PTGX](https://biopharmsignal.com/company/PTGX) — Protagonist Therapeutics Inc - [QTTB](https://biopharmsignal.com/company/QTTB) — Q32 Bio Inc - [HGEN](https://biopharmsignal.com/company/HGEN) — QHUMANIGEN INCD - [RAPT](https://biopharmsignal.com/company/RAPT) — RAPT Therapeutics - [REGN](https://biopharmsignal.com/company/REGN) — Regeneron Pharmaceuticals - [SABS](https://biopharmsignal.com/company/SABS) — SAB Biotherapeutics - [SELB](https://biopharmsignal.com/company/SELB) — Selecta - [STTK](https://biopharmsignal.com/company/STTK) — Shattuck Labs - [SNGX](https://biopharmsignal.com/company/SNGX) — SOLIGENIX - [SYRE](https://biopharmsignal.com/company/SYRE) — Spyre Therapeutics, Inc. - [GPCR](https://biopharmsignal.com/company/GPCR) — Structure Therapeutics - [THAR](https://biopharmsignal.com/company/THAR) — Tharimmune - [THRD](https://biopharmsignal.com/company/THRD) — Third Harmonic Bio - [TLSA](https://biopharmsignal.com/company/TLSA) — Tiziana Life Sciences - [VCNX](https://biopharmsignal.com/company/VCNX) — Vaccinex - [VTYX](https://biopharmsignal.com/company/VTYX) — Ventyx Biosciences, Inc. - [VERA](https://biopharmsignal.com/company/VERA) — Vera Therapeutics - [VIR](https://biopharmsignal.com/company/VIR) — Vir Biotechnology - [VRDN](https://biopharmsignal.com/company/VRDN) — Viridian Therapeutics - [VYNE](https://biopharmsignal.com/company/VYNE) — VYNE Therapeutics Inc. - [XFOR](https://biopharmsignal.com/company/XFOR) — X4 Pharmaceuticals - [XNCR](https://biopharmsignal.com/company/XNCR) — Xencor - [ZLAB](https://biopharmsignal.com/company/ZLAB) — Zai Lab Limited - [ZURA](https://biopharmsignal.com/company/ZURA) — Zura Bio